Genetic Technologies Secures US and ANZ Distribution Rights for PREDICTIX
02 déc. 2020 09h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, the ‘Company’), announced today that they have entered into a...
Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report
23 nov. 2020 16h30 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its...
Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19
17 nov. 2020 08h30 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr....
Genetic Technologies Provides Update on COVID-19 Risk Test
01 oct. 2020 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on the...
Genetic Technologies Provides Update on COVID-19 Disease Severity Test Development
15 sept. 2020 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ:GENE) (“Genetic Technologies” or the "Company") is developing a...
Genetic Technologies Announces US Sales Have Commenced via Online Health Platform
11 sept. 2020 08h33 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”) is delighted to announce that initial sales of its...
Genetic Technologies Regains Compliance with Nasdaq Stockholders Equity Requirement
01 sept. 2020 16h45 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, is...
Genetic Technologies Announces Closing of $5.1 Million Registered Direct Offering
20 juil. 2020 20h30 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 20, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
Genetic Technologies Announces $5.1 Million Registered Direct Offering
16 juil. 2020 08h02 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 16, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
Genetic Technologies Provides Update on COVID-19 Disease Severity Test
15 juil. 2020 08h00 HE
|
Genetic Technologies Ltd
Highlights Genetic Technologies has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in AustraliaThe COVID-19 Severity Risk Test comprises a polygenic risk...